, Décrire les toxidromes liés aux NPS et apparentés identifiés
, Décrire la fréquence des polyintoxications (plusieurs molécules identifiées)
, Décrire la mortalité des intoxications aux NPS et apparentés
, Décrire la morbidité des intoxications aux NPS et apparentés
, Décrire la prise en charge habituelle des intoxications aux NPS et apparentés. D. Critères de jugements secondaires
, Symptômes cliniques observés chez les patients intoxiqués aux NPS et apparentés
, Pourcentage de co-intoxications incluant des NPS et apparentés
, Mortalité hospitalière jusqu'à un mois exprimée en pourcentage
, Pourcentage d'admissions en réanimation jusqu'à 1 mois après l'inclusion, durée d'hospitalisation
, Description des thérapeutiques mises en oeuvre dans les 24h suivant l'admission (perfusions de solutés, médicaments et antidotes administrés, mesures réanimatoires)
,
, Etude prospective, multicentrique avec recrutement consécutif sur une période d'inclusion fixe
, Utilisation d'antidote(s) naloxone ; quantité : ?????????. flumazenil ; quantité : ????????
autre ; précisez lequel et quantité : ??? Administration d'autres médicaments paracétamol ; quantité : ???????? rivotril ; quantité : ??????????. loxapine ; quantité : ?????????.. valium ; quantité : ??????????. dobutamine, précisez posologie : ????. atropine, précisez quantité : ??????.. autre ,
, Mesures réanimatoires remplissage vasculaire ; précisez lequel et quantité : ??????????????? noradrénaline
, précisez médicaments utilisés et quantité : ?????. réanimation cardiopulmonaire: No-flow ?????mn Low-flow ?????mn Adrénaline ?????mg IVD dialyse Etude SkiTox Identifiant Sujet
,
, Cette feuille doit être complétée pour toute sortie du patient avant le terme de l'essai. Date d'arrêt précoce : ??????????????????? jj/mm/aaaa
Cause d'arrêt précoce : retrait de consentement, date ??????????????????? jj/mm/aaaa autres, précisez : ??????????????????? ,
,
,
, Stupéfiants et psychotropes -ANSM : Agence nationale de sécurité du médicament et des produits de santé. Disponible sur, 1990.
Pharmacological and Toxicological Effects of Catha edulis F ,
, Khat Pharmacology and Toxicology. Phytother Res. juill, vol.31, issue.7, pp.1019-1047, 2017.
The newest cathinone derivatives as designer drugs: an analytical and toxicological review, Forensic Toxicol. janv, vol.36, issue.1, pp.33-50, 2018. ,
Khat and synthetic cathinones: a review, Arch Toxicol. janv, vol.88, issue.1, pp.15-45, 2014. ,
,
, Pharmacological characterization of designer cathinones in vitro: Pharmacology of cathinones, Br J Pharmacol. janv, vol.168, issue.2, pp.458-70, 2013.
Kersten BP, McLaughlin ME. Toxicology and Management of Novel Psychoactive Drugs. Ferrell KW, Hill AM, éditeurs, J Pharm Pract. févr, vol.38, issue.2, pp.50-65, 2015. ,
Synthetic Cathinones: Novel Addictive and Stimulatory Psychoactive Substances, vol.215, 2018. ,
Synthetic cathinones related fatalities: an update, Eur Rev Med Pharmacol Sci. janv, vol.22, issue.1, pp.268-74, 2018. ,
The Emergence of Synthetic Cannabinoid Receptor Agonists and Cathinones in the U.S. Armed Forces, Mil Med. sept, vol.177, issue.9, pp.1041-1049, 2012. ,
New and Emerging Illicit Psychoactive Substances, Med Clin North Am. juill, vol.102, issue.4, pp.697-714, 2018. ,
Next generation of novel psychoactive substances on the horizon -A complex problem to face, Drug Alcohol Depend. déc, vol.157, pp.1-17, 2015. ,
Novel Psychoactive Substances and Trends of Abuse: Crit Care Nurs Q, vol.40, pp.374-82, 2017. ,
Novel Drugs of Abuse, Pediatr Rev. févr, vol.40, issue.2, pp.71-79, 2019. ,
New Psychoactive Substances in Pediatric Patients ,
, Pediatr Clin North Am. déc, vol.64, issue.6, pp.1223-1264, 2017.
,
, A Review, Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, vol.41, pp.573-610, 2017.
Death cases involving certain new psychoactive substances: A review of the literature, Forensic Sci Int. mai, vol.298, pp.186-267, 2019. ,
Abuse potential and toxicity of the synthetic cathinones (i.e., « Bath salts »), Neurosci Biobehav Rev, vol.14, issue.2019 ,
Clinical toxicology of newer recreational drugs, Clin Toxicol, vol.49, issue.8, pp.705-724, 2011. ,
Bromo-dragon fly--life-threatening drug ,
, Lakartidningen. 16 avr, vol.105, issue.16, pp.1199-200, 2008.
,
, Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines, J Psychoactive Drugs. 8 août, vol.49, issue.4, pp.289-93, 2017.
Ketamine: An Update on Its Abuse, J Pharm Pract. déc ,
,
, Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine, Clin Toxicol. déc, vol.52, issue.10, pp.1288-91, 2014.
Use of cognitive enhancers: methylphenidate and analogs, p.13 ,
The hallucinogenic world of tryptamines: an updated review, Arch Toxicol. août, vol.89, issue.8, pp.1151-73, 2015. ,
Clinical and epidemiological characteristics of patients with acute drug intoxication admitted to ICU, J Community Hosp Intern Med Perspect, vol.7, issue.4, pp.202-209, 2017. ,
Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project, Forensic Sci Int. oct, vol.243, pp.23-32, 2014. ,
Recreational Use, Analysis and Toxicity of Tryptamines, Curr Neuropharmacol. janv, vol.13, issue.1, pp.26-46, 2015. ,
Fatality due to acute alphamethyltryptamine intoxication, J Anal Toxicol. août, vol.29, issue.5, pp.394-401, 2005. ,
Fatal intoxication involving etryptamine ,
, J Forensic Sci. mai, vol.38, issue.3, pp.721-726, 1993.
Rhabdomyolysis After Ingestion of "Foxy ,
, Mayo Clin Proc. 1 avr, vol.81, issue.4, pp.550-551, 2006.
,
, Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York, On behalf of the ACMT Toxicology Investigators Consortium (ToxIC), vol.376, pp.235-242, 2017.
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study, J Med Toxicol. juin, vol.13, issue.2, pp.146-52, 2017. ,
Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques, Toxicol Anal Clin. mars, vol.27, pp.33-40, 2015. ,
,
, Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil, Forensic Toxicol. janv, vol.36, issue.1, pp.12-32, 2018.
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review, Neuropharmacology. mai, vol.134, pp.121-153, 2018. ,
New synthetic opioids: Part of a new addiction landscape, Neurosci Biobehav Rev, p.0149763418301143, 2018. ,
A Series of Deaths Involving Carfentanil in the UK and Associated Post-mortem Blood Concentrations, J Anal Toxicol. 1 mai, vol.42, issue.4, p.110, 2017. ,
A review: Fentanyl and non-pharmaceutical fentanyls, Drug Alcohol Depend. févr, vol.171, pp.107-123, 2017. ,
, Characteristics of Fentanyl Overdose -Massachusetts, vol.66, issue.14, pp.382-388, 2014.
New psychoactive substances -Production, Drugs -Early Warning System -MDMA, PMMA et 25C-NBOMe : Identification de nouveaux comprimés d'ecstasy fortement concentrés en MDMA et en PMMA ainsi que d'un buvard contenant du 25C-NBO. Disponible sur, vol.30, pp.5-18, 2015. ,
, Décès en relation avec l'abus de médicaments et de substances. Principaux résultats enquête DRAMES, Disponible sur, 2017.
Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project, Handb Exp Pharmacol, vol.252, pp.461-73, 2018. ,
Addressing the Fentanyl Threat to Public Health ,
, DEA Emerging Threat Reports | NDEWS l National Drug Early Warning System l University of Maryland, Disponible sur
The prevalence and associated factors of new psychoactive substance use: A 2016 Thailand national household survey, Addict Behav Rep, vol.7, pp.111-116, 2017. ,
Drug Misuse in Adolescents Presenting to the Emergency Department, Pediatr Emerg Care. juill, vol.33, issue.7, pp.451-457, 2017. ,
Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene, Int J Drug Policy, vol.48, pp.91-99, 2017. ,
Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair, Curr Neuropharmacol, vol.15, issue.5, pp.663-81, 2017. ,
Oral fluid drug analysis in the age of new psychoactive substances, Bioanalysis. avr, vol.8, issue.7, pp.691-710, 2016. ,
Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis, Forensic Sci Int, vol.221, issue.1-3, pp.70-76, 2012. ,
Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA, J Anal Toxicol, vol.40, issue.3, pp.236-245, 2016. ,
Two cases of disseminated intravascular coagulation due to « bath salts » resulting in fatalities, with laboratory confirmation, JAAPA, vol.31, issue.8, pp.1-5, 2018. ,
,
Clinical Toxicology and Management of Intoxications With Synthetic Cathinones, DEA Issues Carfentanil Warning To Police And Public. Disponible sur, vol.26, issue.4, pp.353-360, 2013. ,
,
, Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil, Forensic Toxicol, vol.36, issue.1, pp.12-32, 2018.
Controversies and carfentanil: We have much to learn about the present state of opioid poisoning, Am J Emerg Med, vol.35, issue.11, pp.1743-1748, 2017. ,
Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose, J Pharmacol Exp Ther. 2 avr, 2019. ,
Flubromazolam overdose: A review of a new designer benzodiazepine and the role of flumazenil, Ment Health Clin. 10 mai, vol.9, issue.3, 2019. ,
, Recommendations for Tox Analysis of NPS Deaths in France
Prevalence and Psychosocial Correlates of Party-Drug Use and Associated Problems among University Students in the Netherlands, Subst Use Misuse, vol.15, issue.12, pp.2077-88, 2018. ,
Fatality involving ocfentanil documented by identification of metabolites, Drug Test Anal. juin, vol.10, issue.6, pp.995-1000, 2018. ,
Case reports: Four concomitant non-fatal intoxications with AB-FUBINACA and MDMA, Toxicol Anal Clin. févr, vol.29, issue.1, pp.101-111, 2017. ,
,
, Toxicol Anal Clin. juin, vol.30, issue.2, pp.48-57, 2018.
Opioid toxidrome after cocaine sniffing: first case in Europe of nonfatal overdose by carfentanil laced cocaine. Communication congrès TIAFT présenté à, 2018. ,
, Drug Use on
A Study Using Automated Urine Collection. Eller K, éditeur, PLOS ONE. 2 juin, vol.11, issue.6, p.156786, 2016. ,
, Recommandations de la SFTA pour la réalisation des analyses toxicologiques dans les cas de décès impliquant des NPS -version 2019 -SFTA. Disponible sur